Skip to main content
Top
Published in:

01-06-2025 | Metabolic Dysfunction-Associated Steatotic Liver Disease | Review article

The PI3K/Akt pathway: a target for curcumin’s therapeutic effects

Authors: Mahdieh Aliyari, Sahar Ghoflchi, Seyed Isaac Hashemy, Seyedeh Fatemeh Hashemi, Amirali Reihani, Hossein Hosseini

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2025

Login to get access

Abstract

Purpose

The purpose of this review study is to investigate the effect of curcumin on the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway in various diseases. Curcumin, the main compound found in turmeric, has attracted a lot of attention for its diverse pharmacological properties. These properties have increased the therapeutic potential of curcumin in chronic diseases such as cardiovascular disease, Type 2 diabetes, obesity, non-alcoholic fatty liver disease, kidney disease, and neurodegenerative diseases. One of the main mechanisms of the effect of curcumin on health is its ability to modulate the PI3K/Akt signaling pathway. This pathway plays an important role in regulating vital cellular processes such as growth, cell survival, metabolism, and apoptosis. Disruption of the PI3K/Akt signaling pathway is associated with the incidence of several diseases.

Methods

Electronic databases including PubMed, Google Scholar, and Scopus were searched with the keywords “phosphoinositide 3-kinase” AND “protein kinase B “AND “curcumin” in the title/abstract. Also, following keywords “non-alcoholic fatty liver disease” AND “diabetes” AND “obesity” AND “kidney disease” and “neurodegenerative diseases” was searched in the whole text.

Results

Research indicates that curcumin offers potential benefits for several health conditions. Studies have shown it can help regulate blood sugar, reduce inflammation, and protect the heart, kidneys, and brain.

Conclusion

This protective effect is partially achieved by regulating the PI3K-Akt survival pathway, which helps improve metabolic disorders and oxidative stress. By examining how curcumin affects this vital cell pathway, researchers can discover new treatment strategies for a range of diseases.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
The PI3K/Akt pathway: a target for curcumin’s therapeutic effects
Authors
Mahdieh Aliyari
Sahar Ghoflchi
Seyed Isaac Hashemy
Seyedeh Fatemeh Hashemi
Amirali Reihani
Hossein Hosseini
Publication date
01-06-2025
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2025
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-025-01563-2

Prof. Chantal Mathieu highlights how the absence of rigorous performance standards for continuous glucose monitors in Europe contributes to wide variability in device accuracy, raising important concerns about patient safety.

Supported by: Abbott Diabetes Care

Watch the full video

Prof. Chantal Mathieu highlights how the absence of rigorous performance standards for continuous glucose monitors in Europe contributes to wide variability in device accuracy, raising important concerns about patient safety.

Supported by: Abbott Diabetes Care

Log in / Register to watch the full video

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025: the 85th Scientific Sessions

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s annual meeting.

Read more